Catheter colonization in acute renal failure patients: comparison of central venous and dialysis catheters

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
Bertrand SouweineOusmane Traoré

Abstract

Little is known about vascular access infections in patients with acute renal failure. We prospectively compared infection rates of dialysis catheters (DCs) and central venous catheters (CVCs) in patients in the intensive care unit treated with renal replacement therapy for acute renal failure. The same insertion and maintenance procedures were used for CVCs and DCs. To circumvent the allocation bias caused by severity of patient condition, only patients with both types of catheters were included. A total of 150 CVCs and 130 DCs were analyzed in 99 patients with a mean Simplified Acute Physiology Score II of 67 +/- 21. The major cause of acute renal failure was sepsis (62%). Hospital mortality was 62%. Mean catheter duration was shorter for DCs (6.7 +/- 4.4 days) than CVCs (7.8 +/- 4.9 days; P = 0.03). There was no difference between CVCs and DCs in cumulative incidence of catheter colonization (quantitative catheter cultures > or = 10(3) colony-forming units/mL; 4.7% versus 6.2%; P = 0.58) or incidence density of catheter colonization per 1,000 catheter days (5.9 versus 9.1; P = 0.44, respectively). There also was no difference between CVCs and DCs in cumulative incidence and incidence density regardless of whether catheters w...Continue Reading

References

Jun 9, 1977·The New England Journal of Medicine·D G MakiH W Sarafin
Sep 1, 1990·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·A H MossD E McDowell
May 1, 1987·Archives of Internal Medicine·C Brun-BuissonM Rapin
Oct 21, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·B Canaud
Sep 16, 2000·Intensive Care Medicine·A de MendonçaF Cantraine
Feb 7, 2001·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·C RoncoR Bellomo
Apr 19, 2002·Journal of the American Society of Nephrology : JASN·Ravindra L MehtaGlenn M Chertow
Jun 20, 2002·Critical Care Medicine·J P J WesterUNKNOWN Analysis of Renal Replacement Therapy in the Seriously Ill (ARTIS) Investigators
Oct 18, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Bart J A RijndersWilly E Peetermans
Sep 23, 2003·Critical Care Medicine·Cameron DezfulianSanjay Saint
Dec 16, 2003·Intensive Care Medicine·Benoit MissetJean Carlet
Jan 30, 2004·Journal of the American Society of Nephrology : JASN·Eric A J HosteFrancis A Colardyn
Aug 19, 2004·Blood Purification·Taka-aki NakadaMasaharu Watanabe
Oct 20, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Michael Allon
Jan 29, 2005·Intensive Care Medicine·M E OstermannUNKNOWN Riyadh ICU Program Users Group
Apr 19, 2005·Intensive Care Medicine·Abbas HarbFrançois Blot

❮ Previous
Next ❯

Citations

Nov 24, 2012·Annals of Intensive Care·Natacha MrozekBertrand Souweine
Jun 19, 2010·Clinical Journal of the American Society of Nephrology : CJASN·Jean-Jacques ParientiUNKNOWN Members of the Cathedia Study Group
Nov 15, 2011·Clinical Journal of the American Society of Nephrology : CJASN·Audrey E DuguéUNKNOWN Cathedia Study Group
Aug 22, 2009·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Natasa SkoficRafael Ponikvar
Feb 11, 2015·American Journal of Respiratory and Critical Care Medicine·Bertrand SouweineJean-François Timsit
Jun 3, 2014·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Horng-Ruey ChuaRinaldo Bellomo
Jul 31, 2016·Critical Care : the Official Journal of the Critical Care Forum·Elisabeth CoupezBertrand Souweine
Jul 2, 2014·Antimicrobial Agents and Chemotherapy·Jean-Jacques ParientiUNKNOWN Cathedia Study Group
Mar 16, 2012·The Cochrane Database of Systematic Reviews·Xiaoli GeFei-Long Wang
Apr 17, 2014·Intensive Care Medicine·Jean-François SoubirouFrédérique Schortgen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Soins; la revue de référence infirmière
Bernadette FabregasSylvie Labbé
Scottish Medical Journal
C R Pennington
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række
H Flaatten
Deutsche medizinische Wochenschrift
E Gebert
© 2022 Meta ULC. All rights reserved